CMPX
NASDAQ · Biotechnology

Compass Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.68
-0.08 (-10.24%)
As of Nov 7, 1:52 AM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 17 81%
Hold 4 19%
Sell 0 0%
Price Target
Analyst Price Target +7,754.2% upside
Low Target $36.32
Average Target $53.77
High Target $66.75
Current Price $0.68
Current
$0.68
Target
$53.77
$36.32 $53.77 avg $66.75
Scenario Analysis
Bear Case
$36.32
5,205.3%
Low target
Base Case
$53.77
+7,754.2%
Avg target
Bull Case
$66.75
+9,650.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.88
-90.0% from high
52-Week Low
$0.68
+0.0% from low
Target vs 52W High
$53.77
+681.5% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.13
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%